Insulin in 2016: challenge and constraints to access

Insulin was discovered in 1921, first used by an individual with type 1 diabetes in 1922 and then became widely available in the “Western world”. Challenges of access to insulin have been documented and these relate mainly to issues of availability, price and affordability, particularly in low- and middle-income countries.

Testing the limits - the double burden of diabetes and disaster


Debate - the long-term safety of insulin in type 2 diabetes

More and more frequently insulin is being recommended as an ‘add-on’ to oral hypoglycaemic therapy for the achievement of blood glucose targets in people with established type 2 diabetes. Indeed, there are now trials of insulin therapy in type 2 diabetes from diagnosis. Concerns have been raised in the recent medical literature that long-term insulin therapy in type 2 diabetes increases the risk of cardiovascular disease and some cancers. We have asked specialists in the fields of clinical diabetes and pharmacoepidemiology to comment on the question:

Diabetes voices: one condition, three perspectives

Taming the diabetes monster

Elizabeth Snouffer

Children and diabetes: success and challenge in the developing world

Graham Ogle, Angie Middlehurst and Robyn Short-Hobbs

Debate - Insulin pump therapy: a matter of choice?

Caregiver reports of provider recommended frequency of blood glucose monitoring and actual testing frequency for youth with type 1 diabetes


Joyce P. Yi-Frazier and colleagues for the SEARCH for Diabetes in Youth Study Group

Voices of type 1 diabetes: taking type 1 diabetes to school

Taking type 1 diabetes to school is the subject of the second instalment for our Voices of type 1 diabetes series which features first person accounts of people living with either type 1 or type 2 diabetes and their perspectives on managing the conditions in our world today.

Diversity, debate and new directions

Targeting today’s most contemporary issues, the Basic and Clinical Science Stream may provide this year’s Congress with the biggest buzz, especially in areas of obesity, diabetes complications and new treatment strategies. A range of provocative topics including debates about driving type 2 diabetes prevention and bariatric surgery will be presented. Noteworthy speakers will discuss new treatment options for both types of diabetes and present the latest results of clinical trials. Mark Cooper and Sophia Zoungas talk about the exciting programme this year.